To view a copy of this license, visit About this article Cite this article Zhou, XD., Wong, V.WS
Paragraph IV certification (if filing before patent expiration): If the generic manufacturer believes Novo Nordisk's patents are invalid or not infringed, it can file a Paragraph IV certification
Uchida K., Shiraishi M., Naito Y., Torii Y., Nakamura Y., Osawa T
The cells were exposed to a range of treatments: TGF-1 (10 ng/ml, R&D Systems Inc., Minneapolis, USA), IL-1 (10 ng/ml, R&D Systems Inc., Minneapolis, USA), MCC950 (10 M, Selleck, Houston, TX, USA), 3PO (10 or 30 M, Selleck, Houston, TX, USA), liraglutide (10, 100 or 1000 nM, Selleck, Houston, TX, USA), and sodium L-lactate (20 mM, Sigma-Aldrich, St
Vegetable Glycerin
Cutting through the stress: RNA decay pathways at the endoplasmic reticulum